Benitec Biopharma LTD/ADR — key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2019)

A$16.2M

Net Income/Loss (FY2019)

A$4.1M

Total Assets (FY2019)

A$27.4M

Total Equity (FY2019)

A$23.7M

Cash Flows from Operating Activities (FY2019)

A$5.9M

Source: Benitec Biopharma LTD/ADR 20-F filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.